AU5969980A - Dipeptides - Google Patents

Dipeptides

Info

Publication number
AU5969980A
AU5969980A AU59699/80A AU5969980A AU5969980A AU 5969980 A AU5969980 A AU 5969980A AU 59699/80 A AU59699/80 A AU 59699/80A AU 5969980 A AU5969980 A AU 5969980A AU 5969980 A AU5969980 A AU 5969980A
Authority
AU
Australia
Prior art keywords
dipeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU59699/80A
Other versions
AU541146B2 (en
Inventor
Jean Bouchaudon
Daniel Farge
Claude James
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Industries SA
Original Assignee
Rhone Poulenc Industries SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Industries SA filed Critical Rhone Poulenc Industries SA
Publication of AU5969980A publication Critical patent/AU5969980A/en
Application granted granted Critical
Publication of AU541146B2 publication Critical patent/AU541146B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU59699/80A 1979-06-29 1980-06-27 Dipeptides Ceased AU541146B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7916843A FR2460288A1 (en) 1979-06-29 1979-06-29 NEW DIPEPTIDES, THEIR PREPARATION AND THE MEDICINES THAT CONTAIN THEM
FR7916843 1979-06-29

Publications (2)

Publication Number Publication Date
AU5969980A true AU5969980A (en) 1981-01-08
AU541146B2 AU541146B2 (en) 1984-12-20

Family

ID=9227277

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59699/80A Ceased AU541146B2 (en) 1979-06-29 1980-06-27 Dipeptides

Country Status (17)

Country Link
US (1) US4362716A (en)
JP (1) JPS5645448A (en)
AU (1) AU541146B2 (en)
BE (1) BE884075A (en)
CA (1) CA1251000A (en)
CH (1) CH648043A5 (en)
DE (1) DE3024355A1 (en)
DK (1) DK154435C (en)
FR (1) FR2460288A1 (en)
GB (1) GB2053232B (en)
IE (1) IE49951B1 (en)
IT (1) IT1198331B (en)
LU (1) LU82568A1 (en)
NL (1) NL8003760A (en)
NZ (1) NZ194177A (en)
SE (1) SE448462B (en)
ZA (1) ZA803885B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539155A (en) * 1978-11-14 1985-09-03 Fuisawa Pharmaceutical Company, Ltd. New peptide, process for preparation thereof and use thereof
US4436726A (en) * 1980-12-15 1984-03-13 Fujisawa Pharmaceutical Co., Ltd. N-Acylpeptide compound, processes for the preparation thereof and the pharmaceutical compositions
AU9173582A (en) * 1982-01-05 1983-07-14 Fujisawa Pharmaceutical Co., Ltd. N-acyl peptide
EP0114787B1 (en) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Peptide derivatives
FR2546164B1 (en) * 1983-05-16 1987-07-17 Centre Nat Rech Scient NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ELASTASE INHIBITORS
US5149782A (en) * 1988-08-19 1992-09-22 Tanox Biosystems, Inc. Molecular conjugates containing cell membrane-blending agents
SI9011830B (en) * 1990-09-27 1999-12-31 Univerza V Ljubljani, Fakulteta Za Farmacijo New n-acyldipeptides, processes for their preparation and pharmaceutical preparations which contain them
US7544714B2 (en) * 2004-07-16 2009-06-09 University Of Massachusetts Lipid-amino acid conjugates and methods of use
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
JP5500071B2 (en) * 2008-08-01 2014-05-21 日産化学工業株式会社 Novel lipid dipeptides and gels
ES2662999T3 (en) 2009-09-07 2018-04-10 Nissan Chemical Industries, Ltd. Method for preparing a lipopeptide compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4335111A (en) * 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same

Also Published As

Publication number Publication date
GB2053232A (en) 1981-02-04
JPH0159277B2 (en) 1989-12-15
JPS5645448A (en) 1981-04-25
BE884075A (en) 1980-12-29
GB2053232B (en) 1983-04-07
IT1198331B (en) 1988-12-21
NL8003760A (en) 1980-12-31
AU541146B2 (en) 1984-12-20
NZ194177A (en) 1983-11-18
CH648043A5 (en) 1985-02-28
FR2460288A1 (en) 1981-01-23
DK154435B (en) 1988-11-14
DE3024355A1 (en) 1981-01-15
LU82568A1 (en) 1981-02-02
SE8004790L (en) 1980-12-30
DK277880A (en) 1980-12-30
CA1251000A (en) 1989-03-07
DK154435C (en) 1989-04-10
US4362716A (en) 1982-12-07
IE801341L (en) 1980-12-29
ZA803885B (en) 1981-06-24
SE448462B (en) 1987-02-23
IE49951B1 (en) 1986-01-22
FR2460288B1 (en) 1983-08-26
IT8023073A0 (en) 1980-06-26

Similar Documents

Publication Publication Date Title
AU532879B2 (en) 1-aryl-2-acylamido-3-fluoro-1-propanols
AU532626B2 (en) Monacolink
AU2489984A (en) Arylsulphonyls
AU541091B2 (en) Azolyloxy-carboxylic acid -oxy-amides
AU532090B2 (en) Emmitter
AU532783B2 (en) 4-aroyl-imazol-2-ones
AU535632B2 (en) Cyclo-octapeptides
AU537592B2 (en) Mercaptoacyldipeptides
AU533526B2 (en) Polyether-polyamines
AU529508B2 (en) 6-n-propyl-8alpha-methoxymethyl or -methylmercaptomethyl -ergolines
AU525431B2 (en) Emulsans
AU532884B2 (en) Vinyl-cephalosporins
AU527992B2 (en) 9-aminoalkylfluorenes
AU528665B2 (en) Breathalyser
AU532763B2 (en) 8-aminoalkyl-4-alkylpsoralens
AU541146B2 (en) Dipeptides
AU533807B2 (en) Pyridothienotriazines
AU538025B2 (en) N-cyanoimidate
AU531808B2 (en) Tetrahydrobenzothiazolylimidazolidinones
AU531811B2 (en) Thiazolylidene-oxo-propionitriles
AU546524B1 (en) Tripeptides
AU532359B2 (en) 2-amino-3-benzoyl-phenylacetamides
AU532700B2 (en) Diphenylalkanoether
AU536556B2 (en) Aldehyde-ethers
AU538686B2 (en) 1-substituted-2-pyrrolidinones